AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 10053177
Drug: Bupropion and
RxNorm normalized name: bupropion and naltrexone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupropion and nicotine patch
Trial: 18792548
Drug: Clindamycin phosphate
RxNorm normalized name: Clindamycin Phosphate
DrugBank: Clindamycin (DB01190)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clindamycin phosphate 1.2%-tretinoin 0.025% gel (CLIN/RA)
Trial: 18792548
Drug: Clindamycin phosphate
RxNorm normalized name: Clindamycin Phosphate
DrugBank: Clindamycin (DB01190)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clindamycin phosphate gel 1.2% (CLIN) monotherapy
Trial: 29226465
Drug: Oxygen therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxygen therapy at 6 L min‐1 for 6‐12 h
Trial: 26817716
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil providing 0.7 g EPA+DHA/d
Trial: 29962339
Drug: Thiazide therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiazide therapy
Trial: 21187189
Drug: alpha-lipoic acid
RxNorm normalized name: Alpha-lipoic acid
DrugBank: Lipoic acid (DB00166)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: alpha-lipoic acid 1800 mg/d
Trial: 21187189
Drug: alpha-lipoic acid
RxNorm normalized name: Alpha-lipoic acid
DrugBank: Lipoic acid (DB00166)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: alpha-lipoic acid 1200 mg/d
Trial: 27225735
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg intravenous dexketoprofen prior to surgical incision
Trial: 27225735
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg intravenous dexketoprofen 10 minutes after incision
Trial: 1944470
Drug: Synthetic surfactant
RxNorm normalized name: Synthetic surfactant comprised of DPPC, POPG Na, synthetic SP-C analogue and synthetic SP-B analogue
DrugBank: CHF5633 (DB18696)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Synthetic surfactant (Exosurf, 5 ml/kg body weight)
Trial: 8122302
Drug: No-treatment group
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No-treatment group (placebo)
Trial: 29846770
Drug: Ilaprazole 10
RxNorm normalized name: ilaprazole
DrugBank: Ilaprazole (DB11964)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ilaprazole 10 mg alone
Trial: 29846770
Drug: Triple therapy
RxNorm normalized name: MigreLief Triple Therapy with Puracol Caplet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple therapy (Ilaprazole 10 mg, Clarithromycin 500 mg, Amoxicillin 1000 mg)
Trial: 1388092
Drug: etodolac 600
RxNorm normalized name: etodolac 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: etodolac 600 mg/day
Trial: 28492612
Drug: Topical intranasal
RxNorm normalized name: NALOXONE RESCUE KIT INTRANASAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical intranasal corticosteroid therapy (nasal spray)
Trial: 12499331
Drug: Carbohydrate-rich breakfast
RxNorm normalized name: pyrrolidone carboxylate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbohydrate-rich breakfast (69.9 g carbohydrate and 5.2 g protein)
Trial: 11736884
Drug: Intravenous tropisetron
RxNorm normalized name: tropisetron
DrugBank: Tropisetron (DB11699)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous tropisetron (2 mg)
Trial: 16962481
Drug: Topical anesthetic
RxNorm normalized name: Topical anesthetic
DrugBank: Benzocaine (DB01086)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical anesthetic with EMLA (eutectic mixture of lidocaine and prilocaine)
Trial: 28724883
Drug: Calcium carbonate
RxNorm normalized name: Calcium Carbonate
DrugBank: Calcium carbonate (DB06724)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium carbonate (1000 mg) 3 times a day for 3 days
Trial: 10073740
Drug: GI198745 (dutasteride)
RxNorm normalized name: Dutasteride
DrugBank: Dutasteride (DB01126)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GI198745 (dutasteride) 0.01 to 40 mg single oral doses
Trial: 27792020
Drug: Conventional physical
RxNorm normalized name: hypochlorite
DrugBank: Hypochlorite (DB11123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional physical therapy (3 times/week for 6 weeks)
Trial: 9065178
Drug: Pereyra suspension
RxNorm normalized name: Myrospermum pereirae wood oil
DrugBank: Balsam of Peru (DB11482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pereyra suspension
Trial: 21219106
Drug: 10 ml
RxNorm normalized name: Vial Empty 10 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 ml of 2% lidocaine
Trial: 12228196
Drug: Low-dose involved-field
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose involved-field radiotherapy (LD-IFRT)
Trial: 8281875
Drug: Omeprazole 40
RxNorm normalized name: omeprazole 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 40 mg/day
Trial: 9459113
Drug: N-acetylcysteine (NAC)
DrugBank: Acetylcysteine (DB06151)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: N-acetylcysteine (NAC) 190 mg/kg/day
Trial: 9560175
Drug: Cognitive Therapy
RxNorm normalized name: cognitive therapy software
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Therapy plus graded exposure
Trial: 356683
Drug: Flunisolide nasal
RxNorm normalized name: flunisolide nasal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flunisolide nasal spray (150 microgram/day)
Trial: 10772184
Drug: 30 g
RxNorm normalized name: Lancet Unilet 30 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 g of oral glutamine daily
Trial: 10090348
Drug: Nisoldipine CC
RxNorm normalized name: Nisoldipine
DrugBank: Nisoldipine (DB00401)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nisoldipine CC (10 mg to 40 mg daily)
Trial: 9249116
Drug: All doses
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All doses of ITS
Trial: 23321647
Drug: β‐blockade and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: β‐blockade and losartan (BB-L)
Trial: 10227003
Drug: Systemic hormone
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Systemic hormone replacement therapy (HRT)
Trial: 1662959
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg itraconazole once a day
Trial: 1662959
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg ketoconazole twice a day
Trial: 6161788
Drug: Alcohol alone
RxNorm normalized name: Alcohol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alcohol alone (0.4 g/kg and 0.8 g/kg)
Trial: 25090264
Drug: Increasing the
RxNorm normalized name: THE-630
DrugBank: THE-630 (DB16750)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Increasing the dose of metformin (500 mg/day)
Trial: 7591280
Drug: FEC+G-CSF
RxNorm normalized name: G-CSF
DrugBank: Lenograstim (DB13144)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FEC+G-CSF
Trial: 24622423
Drug: Concurrent rehabilitation
RxNorm normalized name: GLUTATHIONE 12.5 g in 100 mL ORAL LIQUID [K2LTS Brain Rehabilitation]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent rehabilitation (CON)
Trial: 1952204
Drug: Epidural fentanyl
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Epidural fentanyl infusion
Trial: 6636394
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no prophylactic antimicrobial therapy)
Trial: 20214831
Drug: JinQi-Jiangtang tablets
RxNorm normalized name: Jianghuang
DrugBank: Turmeric (DB14276)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: JinQi-Jiangtang tablets (JQJT)
Trial: 21332729
Drug: Granulocyte-colony-stimulating factor
RxNorm normalized name: Granulocyte colony-stimulating factor pegfilgrastim
DrugBank: Pegfilgrastim (DB00019)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Granulocyte-colony-stimulating factor (G-CSF) injection in lower adipose tissue-containing sites (arms and legs) (Group B)
Trial: 17692723
Drug: Tretinoin gel
RxNorm normalized name: Tretinoin Gel
DrugBank: Tretinoin (DB00755)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tretinoin gel microspheres 0.1%
Trial: 18390085
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (not explicitly defined, but implied as no treatment)
Trial: 11060833
Drug: Intravenous parecoxib
RxNorm normalized name: parecoxib
DrugBank: Parecoxib (DB08439)
FDA approved: no
EMA approved: yes
PMDA approved: no
Description: Intravenous parecoxib
Trial: 12495686
Drug: PMX-F and
RxNorm normalized name: F-15599
DrugBank: F-15599 (DB16936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PMX-F and teicoplanin in combination (N=20)
Trial: 20938423
Drug: Klamath algae
RxNorm normalized name: Mastocarpus stellatus algae extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Klamath algae extract (Klamin®, 1600 g/day)
Trial: 19487582
Drug: All drugs
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All drugs
Trial: 29606522
Drug: Concurrent and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent and adjuvant temozolomide chemotherapy
Trial: 28138828
Drug: Docetaxel combined
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Docetaxel combined with resminostat (DR) therapy
Trial: 24656944
Drug: Nasal spray
RxNorm normalized name: Nasal Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nasal spray formulation containing 0.2% sodium hyaluronate alone
Trial: 91436
Drug: Maintenance chemotherapy
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maintenance chemotherapy (MCT) with CCNU, methotrexate, and vinblastine for 2 years
Trial: 26861858
Drug: IV enoxaparin
RxNorm normalized name: enoxaparin
DrugBank: Enoxaparin (DB01225)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV enoxaparin 0.5 mg/kg
Trial: 23153449
Drug: RSV fusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: RSV fusion protein nanoparticle vaccine
Trial: 12394544
Drug: Both solutions
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both solutions
Trial: 9801179
Drug: Prochlorperazine maleate,
RxNorm normalized name: Prochlorperazine Maleate, 5 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prochlorperazine maleate, 10 mg intramuscularly
Trial: 21541462
Drug: Intramuscular (IM)
RxNorm normalized name: intramuscular immunoglobulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular (IM) vaccine administration (40 mg/dose)
Trial: 8194687
Drug: Cyclosporine enemas
RxNorm normalized name: Cyclosporine
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclosporine enemas (350 mg nightly for 4 weeks)
Trial: 31302767
Drug: Oral cryotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral cryotherapy during the whole course of cytotoxic agents administration (arm A)
Trial: 31302767
Drug: Regular oral
RxNorm normalized name: infant formula,regular ORAL PACKET (EA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular oral cryotherapy twice a day (arm C)
Trial: 10880891
Drug: 267 mg
RxNorm normalized name: urea 267 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 267 mg micronised fenofibrate
Trial: 17429632
Drug: Continuous 6-hour
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous 6-hour infusion of l-HOP (oxaliplatin)
Trial: 17414592
Drug: Ciprofibrate 100
RxNorm normalized name: ciprofibrate 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciprofibrate 100 mg daily for 8 weeks
Trial: 15121021
Drug: 0.5 mg
RxNorm normalized name: biotin 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg iv ibandronate injections
Trial: 11262678
Drug: Telephone administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Telephone administration of the VCM1 questionnaire
Trial: 22972399
Drug: Low-dose atorvastatin
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose atorvastatin (10 mg)
Trial: 9476035
Drug: Candesartan cilexetil
RxNorm normalized name: Candesartan Cilexetil
DrugBank: Candesartan cilexetil (DB00796)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Candesartan cilexetil 16 mg once daily
Trial: 22309790
Drug: APBI treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: APBI treatment
Trial: 9288302
Drug: Both FES
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both FES and C‐L operations
Trial: 17460370
Drug: Benidipine administered
RxNorm normalized name: manidipine
DrugBank: Manidipine (DB09238)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Benidipine administered first, then ARB increased (Group B)
Trial: 30076171
Drug: ozanimod (treatment)
DrugBank: Ozanimod (DB12612)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: ozanimod (treatment)
Trial: 22717145
Drug: Therapist behaviours
RxNorm normalized name: Moisturel Therapeutic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Therapist behaviours in internet-delivered cognitive behaviour therapy (iCBT)
Trial: 11823658
Drug: Intravenous tPA
RxNorm normalized name: tPA
DrugBank: Phorbol 12-myristate 13-acetate diester (DB17045)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous tPA
Trial: 25025992
Drug: Pioglitazone 15-30
RxNorm normalized name: pioglitazone 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pioglitazone 15-30 mg/day added on calcium channel blockers (CCBs)
Trial: 19250558
Drug: Antihypertensive treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antihypertensive treatment (indapamide SR 1.5 mg +/‐ perindopril 2‐4 mg)
Trial: 30218695
Drug: GFF MDI
RxNorm normalized name: MDI-P
DrugBank: 3,4-Methylenedioxy-N-isopropylamphetamine (DB06112)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GFF MDI (28.8 μg/10 μg)
Trial: 30218695
Drug: GP MDI
RxNorm normalized name: carbetapentane citrate / guaifenesin Oral Solution [Pulmari-GP]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GP MDI (14.4 μg)
Trial: 22967772
Drug: Olanzapine treatment
RxNorm normalized name: Olanzapine
DrugBank: Olanzapine (DB00334)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Olanzapine treatment for 8 weeks
Trial: 2262371
Drug: Six hyperthermia
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Six hyperthermia treatments
Trial: 30391912
Drug: Dexmedetomidine (Dex)
DrugBank: Dexmedetomidine (DB00633)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Dexmedetomidine (Dex) administration (1 µg/kg loading dose before anaesthesia induction and 0.5 µg/kg/h infusion during surgery)
Trial: 27206218
Drug: Pertuzumab plus
RxNorm normalized name: Pertuzumab
DrugBank: Pertuzumab (DB06366)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Pertuzumab plus topotecan (1.25 mg/m days 1-5 every 3 weeks)
Trial: 10391557
Drug: Intraoperative radiation
RxNorm normalized name: allantoin
DrugBank: Allantoin (DB11100)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intraoperative radiation therapy (IORT) of 12-25 Gy
Trial: 29311072
Drug: Cefiderocol 500
RxNorm normalized name: Cefiderocol
DrugBank: Cefiderocol (DB14879)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Cefiderocol 500 mg
Trial: 23964144
Drug: Whole dose
RxNorm normalized name: Betula lenta whole
DrugBank: Betula lenta whole (DB14164)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whole dose NaP preparation (compared to half-dose PEG plus bisacodyl)
Trial: 2963205
Drug: Percutaneous oestrogen
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Percutaneous oestrogen therapy for 2 years, opposed by oral micronized progesterone (200 mg) during the second year
Trial: 18547537
Drug: Retinal implants
RxNorm normalized name: retinaldehyde
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Retinal implants (neural retinal progenitor cell layers with retinal pigment epithelium)
Trial: 21160192
Drug: Sustained-release dinoprostone
RxNorm normalized name: Dinoprostone
DrugBank: Dinoprostone (DB00917)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Sustained-release dinoprostone vaginal pessary followed 6 h later by high-dose oxytocin infusion
Trial: 21160192
Drug: Sustained-release dinoprostone
RxNorm normalized name: Dinoprostone
DrugBank: Dinoprostone (DB00917)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Sustained-release dinoprostone vaginal pessary with concurrent high-dose oxytocin infusion
Trial: 21160192
Drug: Sustained-release dinoprostone
RxNorm normalized name: Dinoprostone
DrugBank: Dinoprostone (DB00917)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Sustained-release dinoprostone pessary followed 6 h later by high-dose oxytocin
Trial: 2683685
Drug: Self-instruction treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Self-instruction treatment using a modified version of the LOGO computer language (REFLECT) and videotape feedback
Trial: 16722837
Drug: Aspirin users
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin users
Trial: 17215531
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of nevirapine
Trial: 1506045
Drug: 2 mL
RxNorm normalized name: ethanol 2 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mL of normal saline
Trial: 7773815
Drug: Active motion
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active motion in combination with continuous passive motion (CPM)
Trial: 31356973
Drug: Conservative treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conservative treatment (CT)
Trial: 25151042
Drug: Quadrivalent meningococcal
RxNorm normalized name: MENINGOCOCCAL B
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quadrivalent meningococcal conjugate vaccine (MCV4) in PSV-exposed/MCV4 group
Trial: 9525435
Drug: Cidofovir 5
RxNorm normalized name: Cidofovir
DrugBank: Cidofovir (DB00369)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cidofovir 5 mg/kg once weekly for 2 weeks, then maintenance therapy with 5 mg/kg once every other week
Trial: 26115690
Drug: Pulsed high-intensity
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pulsed high-intensity laser therapy (HILT) plus routine physical therapy program (RPTP)
Trial: 11391598
Drug: Preoperative chemotherapy
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Preoperative chemotherapy (Arm B) with partial response
Trial: 9258754
Drug: Vitamin D3
RxNorm normalized name: Vitamin D3
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D3 supplementation (400 IU daily for at least 2 years)
Trial: 22800378
Drug: Department of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Department of Geriatrics (DG) treatment pathway including comprehensive geriatric assessment, pain relief, hydration, oxygenation, nutrition, elimination, prevention and management of delirium, assessment of falls and osteoporosis, early mobilization, and individualized rehabilitation plans.
Trial: 22800378
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment in the Department of Orthopaedic Surgery (DOS).
Trial: 19841897
Drug: Low-dose vasopressin
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose vasopressin (0.01-0.03 U/min)
Trial: 8721275
Drug: Intracavernous administration
RxNorm normalized name: bivalirudin
DrugBank: Bivalirudin (DB00006)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intracavernous administration of moxisylyte with a tourniquet
Trial: 8721275
Drug: Intracavernous administration
RxNorm normalized name: bivalirudin
DrugBank: Bivalirudin (DB00006)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intracavernous administration of moxisylyte without a tourniquet
Trial: 18184934
Drug: Simplified version
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Simplified version of a habit reversal treatment (awareness training, self-monitoring, competing responses, and social support)
Trial: 8918509
Drug: Supportive group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supportive group sessions and free nicotine supplementation (patches, chewing gum)
Trial: 27998859
Drug: Magnesium sulphate
RxNorm normalized name: Magnesium sulphate
DrugBank: Magnesium (DB14513)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Magnesium sulphate infusion
Trial: 30962703
Drug: Best medical
RxNorm normalized name: calcium polycarbophil
DrugBank: Calcium polycarbophil (DB14684)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Best medical therapy
Trial: 6983966
Drug: Carprofen 150
RxNorm normalized name: Carprofen
DrugBank: Carprofen (DB00821)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Carprofen 150 mg daily, b.i.d. administration
Trial: 21114605
Drug: Linagliptin 5
RxNorm normalized name: linagliptin 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Linagliptin 5 mg once daily